Sage Rhino Capital’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,439
Closed -$204K 241
2023
Q4
$204K Buy
+2,439
New +$204K 0.05% 203